Detalhe da pesquisa
1.
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial.
Lancet Oncol
; 19(7): 940-952, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29875066
2.
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.
N Engl J Med
; 369(2): 134-44, 2013 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-23724846
3.
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial.
Lancet
; 384(9948): 1109-17, 2014 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25034862
4.
Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma.
Cancer Discov
; 12(3): 644-653, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34764195
5.
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Washout Period and Concomitant Medication Work Group.
Clin Cancer Res
; 27(9): 2400-2407, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33563635
6.
A novel G-quadruplex-forming GGA repeat region in the c-myb promoter is a critical regulator of promoter activity.
Nucleic Acids Res
; 36(6): 1755-69, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18252774
7.
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial.
J Clin Oncol
; 38(3): 193-202, 2020 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31790344
8.
Formation of a unique end-to-end stacked pair of G-quadruplexes in the hTERT core promoter with implications for inhibition of telomerase by G-quadruplex-interactive ligands.
J Am Chem Soc
; 131(31): 10878-91, 2009 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-19601575
9.
Pembrolizumab Utilization and Outcomes for Advanced Melanoma in US Community Oncology Practices.
J Immunother
; 41(2): 86-95, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29252916
10.
Pembrolizumab Exposure-Response Assessments Challenged by Association of Cancer Cachexia and Catabolic Clearance.
Clin Cancer Res
; 24(23): 5841-5849, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29891725
11.
Mechanism of PNA transport to the nuclear compartment.
Ann N Y Acad Sci
; 1082: 27-30, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17145921
12.
Peptide nucleic acid conjugates: synthesis, properties and applications.
Curr Top Med Chem
; 5(12): 1119-31, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16248787
13.
Targeting and regulation of the HER-2/neu oncogene promoter with bis-peptide nucleic acids.
Oligonucleotides
; 15(1): 36-50, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15788899
14.
Renal cell carcinoma: rationale and development of therapeutic inhibitors of angiogenesis.
Hematol Oncol Clin North Am
; 18(5): 1143-59, ix-x, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15474339
15.
Tolerability, safety and pharmacokinetics of ridaforolimus in combination with bicalutamide in patients with asymptomatic, metastatic castration-resistant prostate cancer (CRPC).
Cancer Chemother Pharmacol
; 72(4): 909-16, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23921574
16.
Site-selective DNA binding drugs.
Chem Biol
; 10(10): 895-7, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14583253
17.
Voreloxin, a first-in-class anticancer quinolone derivative, in relapsed/refractory solid tumors: a report on two dosing schedules.
Clin Cancer Res
; 16(7): 2167-75, 2010 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20233886
18.
PNA-nitrogen mustard conjugates are effective suppressors of HER-2/neu and biological tools for recognition of PNA/DNA interactions.
Bioconjug Chem
; 17(1): 214-22, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16417271
19.
Evidence for the presence of a guanine quadruplex forming region within a polypurine tract of the hypoxia inducible factor 1alpha promoter.
Biochemistry
; 44(49): 16341-50, 2005 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-16331995
20.
A bis-alkylating triplex forming oligonucleotide inhibits intracellular reporter gene expression and prevents triplex unwinding due to helicase activity.
Biochemistry
; 42(17): 5013-24, 2003 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-12718544